GOUT CHRONIC

Clinical trials for GOUT CHRONIC explained in plain language.

Never miss a new study

Get alerted when new GOUT CHRONIC trials appear

Sign up with your email to follow new studies for GOUT CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New drug aims to tame painful gout flares

Disease control Ongoing

This study is testing whether a new medication called AR882 can effectively lower uric acid levels and reduce painful gout attacks. It involves 750 people with gout who will take either AR882 or a placebo for 12 months. Researchers want to see if AR882 helps prevent gout flares a…

Matched conditions: GOUT CHRONIC

Phase: PHASE3 • Sponsor: Arthrosi Therapeutics • Aim: Disease control

Last updated Apr 02, 2026 03:56 UTC

GOUT CHRONIC

Get alerted when new GOUT CHRONIC trials appear

New drug aims to tame painful gout flares